Acetyl-Amyloid beta 25-35, >=97% (HPLC)

Amino Acid Sequence

Ac-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met

Application

Acetyl-Amyloid ? 25-35 has been used to prepare rat models with Alzheimer’;s disease.

General description

Amyloid-? (A?) peptides are a major component of the senile plaques characteristic of the Alzheimer brain. It is a type- I transmembrane protein. The amyloid ? precursor protein is cleaved to amyloid peptides 36-43 amino acids in length. A? (25-35) represents the region that aggregates during plaque formation and is a functional domain implicated in both neurotrophic and neurotoxic effects. The gene encoding amyloid-? is localized on human chromosome 21. Acetylation may improve stability in in vitro and in vivo assays.

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Manufacturer Composition Storage Temp. Form Assay Price Quantity
3592250 Acetyl-Amyloid beta 25-35, >=97% (HPLC) SIGMA-ALDRICH Peptide Content, ≥70% −20°C lyophilized ≥95% (HPLC)
£157.39 (exc VAT) per 1MG
-
+
3592251 Acetyl-Amyloid beta 25-35, >=97% (HPLC) SIGMA-ALDRICH Peptide Content, ≥70% −20°C lyophilized ≥95% (HPLC)
£452.68 (exc VAT) per 5MG
-
+